- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 12, 2025 | 14.29M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 12.76M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 10.14M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 8.53M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 8.68M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $178.64K |
| Capex | Q3 2025 · Sep 30, 2024 | $10.2K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$11.33M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $167.64K |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $10.54K |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $4.05K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $23.08M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $15.7M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $11.23M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $2.86M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$12.73M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$9.56M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$6.01M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$1.48M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $2.67M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | −$11M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$5.05M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $21.22M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $21.61M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $27.89M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $28.11M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $25M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $18.45M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $30.75M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $22.1M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.18 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.55 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.17 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.28 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.18 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.55 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.17 |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $1.18M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $4.9M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $2.68M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $10.97M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$3.56M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$11.96M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$4.02M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$4.38M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$4.7M |
| Net Income | Q3 2025 · Sep 30, 2024 | $1.45M |
| Net Income | Q3 2025 · Jun 30, 2024 | $12.91M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$6.76M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$3.67M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$12.08M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$4.68M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$18.06M |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.26K |
| Revenue | Q3 2025 · Sep 30, 2025 | $6.52K |
| Revenue | Q3 2025 · Sep 30, 2024 | $41.69K |
| Revenue | Q3 2025 · Sep 30, 2024 | $73.43K |